Does amlodipine cause gingival recession?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amlodipine Causes Gingival Hyperplasia, Not Gingival Recession

Amlodipine does not cause receding gum lines (gingival recession); instead, it causes the opposite problem—gingival hyperplasia (gum overgrowth). This is a well-documented adverse effect of calcium channel blockers, including amlodipine, and is explicitly listed in multiple clinical guidelines 1.

Understanding the Gingival Effect

The 2015 AHA/ATS Pediatric Pulmonary Hypertension Guidelines clearly list "gum hyperplasia" as an adverse effect of amlodipine, along with other calcium channel blockers like nifedipine and diltiazem 1. This represents gingival overgrowth—the gums become enlarged and swollen—which is the opposite of recession where gums pull away from teeth.

Clinical Prevalence and Characteristics

Recent research demonstrates that amlodipine-induced gingival enlargement occurs in 28.7% to 37% of patients taking the medication 2, 3. The condition typically:

  • Develops after at least 3-6 months of therapy
  • Shows dose-dependent correlation (higher doses = greater risk) 2, 3
  • Presents most commonly as Grade 1 enlargement (mild overgrowth affecting interdental papillae)
  • Can progress to more severe grades in 2-3% of cases 2, 3

The risk increases significantly with the 10 mg dose compared to 5 mg 4, 5.

Why This Matters Clinically

The British Association of Dermatologists guidelines on ciclosporin (which also causes gingival hyperplasia) note that calcium channel blockers like amlodipine used to treat drug-induced hypertension can compound this effect: "Calcium antagonists have the disadvantage of inducing gingival hyperplasia, possibly adding to this effect" 6.

Management Algorithm

If a patient on amlodipine develops gingival problems:

  1. Assess the gingival change: Is it overgrowth/swelling (hyperplasia) or recession?
  2. If hyperplasia is present:
    • Consider dose reduction if blood pressure control allows
    • Substitute with an alternative antihypertensive class (ACE inhibitor, ARB, or thiazide diuretic) 4, 5, 7
    • Refer for dental evaluation and scaling/root planing
    • Emphasize meticulous oral hygiene from treatment initiation 2, 3
  3. If true recession is present: This is NOT caused by amlodipine—investigate other causes (periodontal disease, aggressive brushing, aging)

Common Pitfall

Do not confuse gingival hyperplasia with gingival recession. These are opposite conditions. Amlodipine causes tissue overgrowth, not tissue loss. If a patient reports "receding gums" while on amlodipine, the actual problem is likely either misidentified hyperplasia or unrelated periodontal disease.

The 2017 ACC/AHA Hypertension Guidelines note that dihydropyridine calcium channel blockers like amlodipine are "associated with dose-related pedal edema" 8, but gingival effects, while documented in other guidelines 1, represent a less commonly emphasized but clinically significant adverse effect that warrants patient counseling before initiating therapy 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.